Cullinan Therapeutics CEO Nadim Ahmed receives $39M in 2021
Cullinan Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
Cullinan Therapeutics reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, four executives at Cullinan Therapeutics received on average a compensation package of $13M, a 190% increase compared to previous year.
Average pay of disclosed executives at Cullinan Therapeutics
Nadim Ahmed, Chief Executive Officer, received $39M in total. 98% of Ahmed's compensation, or $38M, was in option awards. Ahmed also received $699K in bonus and $125K in salary.
Owen Hughes, Chief Executive Officer, received a compensation package of $6.8M, which increased by 4% compared to previous year. 89% of the compensation package, or $6M, was in option awards.
Patrick Baeuerle, Chief Scientific Officer, earned $4.7M in 2021, a 13% decrease compared to previous year.
Jeffrey Trigilio, Chief Financial Officer, received $2.7M in 2021, which increases by 53% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 29, 2022.